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Maternal lipids and leptin 
concentrations are associated with 
large-for-gestational-age births: a 
prospective cohort study
Dayana Rodrigues Farias1, Lucilla Poston2, Ana Beatriz Franco-Sena1, Antônio Augusto Moura 
da Silva3, Thatiana Pinto1, Lívia Costa de Oliveira1 & Gilberto Kac1
The change in maternal lipid, leptin and adiponectin concentrations during pregnancy and infant birth 
weight (BW) is still poorly characterized. Thus, the aim of the study was to evaluate the association of 
maternal lipids, leptin and adiponectin throughout pregnancy with large-for-gestational-age (LGA) 
births and BW z-score. A prospective cohort of 199 mothers was followed during pregnancy in Rio 
de Janeiro, Brazil. The statistical analyses comprised multiple logistic and linear regression. Women 
delivered 36 LGA and 11 small-for-gestational-age newborns. HDL-c rate of change throughout 
pregnancy was negatively associated with BW z-score (β = −1.99; p = 0.003) and the delivery of a 
LGA newborn (OR = 0.02; p = 0.043). Pregnancy baseline concentration of log leptin was positively 
associated (OR = 3.92; p = 0.025) with LGA births. LDL-c rate of change throughout pregnancy was 
positively associated with BW z-score (β = 0.31; p = 0.004). Log triglycerides and log adiponectin were 
not significantly associated with BW z-score or LGA birth. In conclusion, a higher log leptin pregnancy 
baseline concentration and a lower HDL-c rate of change during pregnancy were associated with higher 
odds of having a LGA newborn. These maternal biomarkers are important to foetal growth and could be 
used in prenatal care as an additional strategy to screen women at risk of inadequate BW.
Birth weight (BW) has been associated with several adverse outcomes, both early and late in life. High BW has 
been associated with caesarean section, obesity and diabetes later in life1, 2. BW is influenced by maternal dietary 
intake, nutritional status, height, biological markers, gestational age at delivery, smoking habits and socioeco-
nomic and demographic characteristics3–8.
Maternal serum cholesterol (HDL-c and LDL-c) is transported across the placenta9–11. It is suggested that 
although the foetal liver synthesizes most foetal cholesterol, maternal cholesterol is crucial in providing choles-
terol to the foetus, especially during early pregnancy9, 10. Experimental studies indicate that maternal cholesterol 
affects foetal sterol metabolism and the metabolic functions of extra embryonic foetal tissues, impacting foetal 
development12, 13. Positive associations have been reported between maternal triglycerides (TG) and BW, espe-
cially in pregnancies complicated by gestational diabetes, and negative associations have been reported between 
HDL-c and BW6, 14–16. However, some studies have failed to find significant associations. Thus, there is no con-
sensus regarding which lipid fractions are involved and how pregnancy-related changes in lipids may influence 
BW6, 14, 17.
Maternal adiposity is also an important predictor of BW18. Maternal blood concentrations of fat-derived hor-
mones, such as leptin and adiponectin, significantly change during pregnancy18, 19. However, although an increase 
in leptin and a decrease in adiponectin concentrations are expected, studies have reported that women experience 
different rates of change of adipokines during pregnancy depending on pre-pregnancy body mass index (BMI)20–
22. In this way, the pregnancy change in adipokines could be a potential mechanism linking maternal adiposity to 
foetal weight gain. Based on these assumptions, associations between maternal leptin and adiponectin concentra-
tions and BW have been investigated, but reports are still contradictory17, 23.
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Thus, considering the importance of foetal development and subsequent BW for health in early and late life 
and the lack of consensus regarding the associations between maternal lipids, leptin and adiponectin and BW, the 
aim of this study was to evaluate the association of maternal lipid, leptin and adiponectin concentrations through-
out pregnancy with BW z-score and the prevalence of large-for-gestational-age (LGA) births.
Results
We evaluated data from 199, 178 and 180 women during the first, second and third gestational trimesters, respec-
tively (9.5% were lost to follow-up). A total of 36 (18.1%) women delivered LGA newborns, whereas 11 were 
small-for-gestational-age (SGA, 5.5%). The mean gestational age at delivery was 38.8 (SD: 1.7) weeks (data not 
shown in tables).
Women had a mean age of 26.8 (SD: 5.5) years and an early pregnancy BMI of 25.4 (SD: 4.6) kg/m² at the 
study baseline. The mean lipid concentrations significantly increased throughout pregnancy: HDL-c by 15.9% 
(mean increase: 6.9 mg/dL; SD: 8.7); LDL-c by 43.4% (mean increase: 40.1 mg/dL; SD: 26.4); and total cholesterol 
(TC) by 40.5% (mean increase: 63.0 mg/dL; SD: 32.0). The highest mean percentage increase was observed for 
TG concentration, 114.8% (mean increase: 79.9 mg/dL; SD: 40.8). Women who delivered LGA newborns pre-
sented higher means of early pregnancy BMI (27.0 vs. 25.3 kg/m²; p = 0.042), second trimester glycaemia (82.0 
vs. 78.3 mg/dL; p = 0.049) and first trimester leptin concentrations (27.7 vs. 19.6 ng/dL; p = 0.001), as well as lower 
third trimester adiponectin concentrations (4.6 vs. 6.3 µg/mL; p = 0.045) compared with those who delivered 
appropriate-for-gestational-age (AGA) newborns (Table 1).
Seventy-six (40.4%) women were classified as overweight or obese, 12 (6.0%) smoked during the first tri-
mester, and 112 (56.3%) reported >8 years of schooling. We observed a higher frequency of LGA births among 
women with early pregnancy overweight or obesity (55.9%) compared to those with normal weight (38.2%) 
(Table 2).
Figures 1–6 present longitudinal changes in the maternal biomarkers stratified according to BW category. The 
analyses revealed that the HDL-c rate of change per gestational week was significantly lower in the LGA group 
compared to the AGA and SGA groups (Fig. 1). We did not observe significant differences in longitudinal changes 
of LDL-c (Fig. 2), TC (Fig. 3), TG (Fig. 4), leptin (Fig. 5) or adiponectin (Fig. 6) between BW groups. However, 
women who delivered LGA newborns presented higher early pregnancy leptin concentrations compared with 
those who delivered AGA or SGA newborns (Fig. 5).
Mean BW z-scores tended to be higher in women who practiced leisure time physical activity (LTPA) before 
pregnancy than in those who did not (0.52 vs. 0.25; p = 0.119), with one or more parturitions than in nulliparous 
(0.42 vs. 0.14; p = 0.072), and in women with overweight/obesity than in those with a normal weight at early 
pregnancy (0.48 vs. 0.22; p = 0.103) (Table 3).
HDL-c rate of change during pregnancy was negatively associated with LGA birth (slope OR = 0.01; 95%CI: 
0.0002 to 0.29; p = 0.009), while pregnancy baseline concentrations of log leptin were positively associated with 
LGA birth (intercept OR = 3.88; 95%CI: 1.49 to 10.09; p = 0.005) (Table 4). The association between HDL-c (rate 
of change/slope OR = 0.02; 95%CI: 0.0003 to 0.88; p = 0.043) and log leptin (pregnancy baseline concentrations/
intercept OR = 3.92; 95%CI: 1.18 to 12.95; p = 0.025) with LGA births persisted even in the fully adjusted model 
(Table 4, model 3).
LDL-c rate of change per gestational week during pregnancy (slope) was positively associated with BW z-score 
(β = 0.31; 95%CI: 0.10 to 0.52; p = 0.004), whereas HDL-c rate of change was negatively associated with BW 
z-score (β = −1.99; 95%CI: −3.30 to −0.68; p = 0.003), even after adjustments. The pregnancy baseline log leptin 
concentrations were directly associated with BW z-scores after adjustment for confounders (β = 0.43; 95%CI: 
0.10 to 0.75; p = 0.010), but the associations were no longer significant after inclusion of early pregnancy BMI in 
the model (0.19; 95%CI: −0.18 to 0.56; p = 0.306) (Table 5). The log TG and log adiponectin pregnancy baseline 
concentrations and rates of change during pregnancy were not significantly associated with BW z-score or LGA 
birth (Tables 4 and 5).
We did not find significant interactions between maternal BMI and lipids, leptin or adiponectin on BW 
z-score or LGA births in crude or adjusted models (data not shown in tables).
Discussion
This study has two main findings. First, the HDL-c rate of change during pregnancy was negatively associated 
with BW z-score and the delivery of LGA newborns, whereas the pregnancy baseline log leptin concentrations, 
but not the rate of change, were positively associated with these outcomes. Secondly, the LDL-c rate of change 
over time was positively associated with BW z-score. We did not observe significant associations between gesta-
tional changes of log TG and log adiponectin and BW z-score or LGA births in the adjusted models. Moreover, 
BMI was not an effect modifier of the associations of lipids and leptin with BW z-score and LGA births in our 
sample.
One limitation of this study was the lack of an oral glucose tolerance test to diagnose gestational diabetes mel-
litus (GDM), which is strongly associated with BW24–26. Thirteen women reported a diagnosis of GDM during 
pregnancy (6.4%). We compared the analyses with and without these women and found no significant changes in 
the results. Furthermore, all the adjusted models were controlled for fasting glucose. Multiple regression models 
were additionally adjusted for other established confounders such as early pregnancy BMI, gestational weight 
gain (GWG) and smoking habit3, 5, 7, 27. A large number of statistical comparisons were carried out, but no adjust-
ments were made for multiple comparisons. This is also a limitation of our study, as it inflates the likelihood of 
Type I errors. The small number of cases of LGA can be considered another limitation of the study. However, 
even with a modest sample size, we were able to find statistically significant associations, indicating a stronger 
relationship between lipids and log leptin and BW z-score/LGA. We only measured total adiponectin in our study. 
Therefore, the lack of information regarding the high-molecular-weight (HMW) adiponectin, which is the form 
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that has been reported as more strongly correlated to many outcomes such as diabetes and cardiovascular dis-
ease28–30, limits our conclusions regarding the effect of adiponectin in BW. The measurement of lipid, leptin and 
adiponectin concentrations during all three trimesters of pregnancy is a strength of this study. Furthermore, BW 
z-score and LGA were calculated using a population-based international growth curve that has evaluated 20,486 
women and their newborns in eight geographically defined urban populations, including Brazil31. The study 
design enabled us to better understand the relationship between the metabolic changes in maternal biomarkers 
and infant BW. The use of a two-stage procedure32 to model the association between time-dependent exposures 
and a non-time-varying outcome was also a strength of this study. This procedure considers that the repeated 
Total sample SGA1 AGA1 LGA1
p2 p3n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD)
Age (years) 199 26.8 (5.5) 11 25.0 (5.9) 152 26.8 (5.6) 36 26.9 (4.9) 0.952 0.290
Education (years of schooling) 199 8.7 (2.9) 11 8.6 (2.0) 152 8.6 (3.0) 36 8.8 (2.6) 0.856 0.987
Early pregnancy BMI (kg/m²) 199 25.4 (4.6) 11 21.8 (2.0) 152 25.3 (4.4) 36 27.0 (5.2) 0.042 0.011
Pre-pregnancy energy intake 
(kcal/day) 199 2312 (688) 11 2576 (738) 152 2288 (719) 36 2330 (521) 0.741 0.202
Gestational weight gain (kg) 189 11.8 (4.3) 9 10.6 (3.6) 147 11.6 (4.3) 33 12.5 (4.4) 0.280 0.465
Glycaemia (mg/dL)
 1st T 198 84.3 (9.2) 11 85.5 (7.1) 151 84.5 (9.8) 36 82.8 (7.4) 0.329 0.738
 2nd T 171 79.0 (9.6) 8 78.0 (7.9) 131 78.3 (9.6) 32 82.0 (9.7) 0.049 0.934
 3rd T 174 80.0 (11.8) 9 75.6 (5.4) 136 80.3 (12.5) 29 79.8 (9.2) 0.927 0.262
Mean change (1st to 3rd T) 174 −4.2 (13.7) 9 −11.7 (7.5) 136 −3.8 (14.5) 29 −3.6 (10.8) 0.924 0.112
HDL-cholesterol (mg/dL)
 1st T 199 47.9 (8.2) 11 44.7 (6.5) 152 47.9 (8.3) 36 49.1 (7.6) 0.401 0.224
 2nd T 178 57.4 (9.9) 9 57.7 (11.7) 137 57.6 (9.9) 32 56.6 (9.7) 0.617 0.991
 3rd T 180 54.8 (9.9) 10 57.0 (10.8) 141 55.0 (9.8) 29 53.3 (10.3) 0.398 0.542
Mean change (1st to 3rd T) 180 6.9 (8.7) 10 11.1 (6.0) 141 7.0 (8.6) 29 4.3 (3.3) 0.215 0.169
LDL-cholesterol (mg/dL)
 1st T 199 96.0 (21.1) 11 85.6 (21.8) 152 96.3 (21.9) 36 97.9 (16.1) 0.690 0.120
 2nd T 178 127.0 (28.7) 9 106.6 (27.7) 137 126.3 (28.3) 32 135.9 (27.9) 0.085 0.046
 3rd T 180 136.7 (33.2) 10 107.2 (31.0) 141 137.6 (33.0) 29 142.3 (30.7) 0.481 0.005
Mean change (1st to 3rd T) 180 40.1 (26.4) 10 24.9 (18.6) 141 40.7 (26.2) 29 42.2 (28.5) 0.778 0.080
Total cholesterol (mg/dL)
 1st T 199 159.8 (27.8) 11 144.7 (26.7) 152 160.3 (29.2) 36 162.5 (20.3) 0.675 0.088
 2nd T 178 210.8 (35.8) 9 190.6 (35.9) 137 210.2 (35.9) 32 218.8 (33.5) 0.218 0.114
 3rd T 180 223.2 (40.8) 10 194.9 (39.8) 141 224.3 (40.8) 29 227.6 (39.0) 0.686 0.029
 Mean change (1st to 3rd T) 180 63.0 (32.0) 10 53.1 (23.6) 141 63.3 (31.6) 29 64.6 (36.1) 0.848 0.344
Triglycerides (mg/dL)
 1st T 199 79.5 (31.9) 11 71.8 (31.4) 152 80.6 (33.8) 36 77.2 (22.7) 0.569 0.406
 2nd T 178 131.6 (48.9) 9 131.3 (58.5) 137 131.6 (50.8) 32 131.6 (38.2) 0.995 0.986
 3rd T 180 158.2 (49.4) 10 153.4 (60.5) 141 158.2 (51.3) 29 160.0 (35.9) 0.859 0.777
 Mean change (1st to 3rd T) 180 79.9 (40.8) 10 85.2 (48.9) 141 78.0 (41.5) 29 87.8 (34.5) 0.234 0.616
Leptin (ng/dL)
 1st T 199 20.7 (13.7) 11 14.5 (11.5) 152 19.6 (12.7) 36 27.7 (16.2) 0.001 0.200
 2nd T 178 33.0 (20.2) 9 34.0 (24.4) 137 31.4 (19.6) 32 38.2 (21.3) 0.103 0.746
 3rd T 178 32.2 (21.7) 10 36.2 (36.1) 139 31.0 (20.2) 29 36.6 (22.8) 0.184 0.461
 Mean change (1st to 3rd T) 178 11.7 (18.0) 10 17.9 (32.8) 139 11.4 (17.0) 29 11.0 (17.1) 0.902 0.301
Adiponectin (µg/mL)
 1st T 199 6.0 (3.9) 11 7.5 (4.3) 152 6.1 (3.4) 36 5.3 (5.4) 0.272 0.177
 2nd T 173 7.0 (5.9) 9 5.7 (2.8) 132 7.4 (6.3) 32 6.0 (4.3) 0.255 0.438
 3rd T 177 6.1 (4.2) 10 8.8 (7.2) 138 6.3 (4.2) 29 4.6 (2.0) 0.045 0.083
 Mean change (1st to 3rd T) 177 0.6 (3.6) 10 2.8 (6.6) 138 0.51 (3.6) 29 0.04 (2.0) 0.499 0.075
Table 1. Pregnancy characteristics according to birth weight categories in a sample of pregnant women and 
their newborns followed at a public health centre in Rio de Janeiro city, Brazil, 2009–2012. 1Birth weight 
was classified according to the international foetal and newborn growth consortium for the 21st Century 
(Intergrowth-21st) curves. 2p-value refers to Student’s t test comparison between AGA and LGA. 3p-value refers 
to Student’s t test for comparison between AGA and SGA. AGA = adequate for gestational age; BMI = Body 
mass index; HDL-c = high density lipoprotein; LDL-c = low density lipoprotein; LGA = large for gestational 
age; SD = standard deviation; SGA = small for gestational age; T = trimester.
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measures are correlated, accounts for different rates of change in the exposures and uses their longitudinal pre-
dictions to evaluate the association with the outcome.
The HDL-c rate of change during pregnancy was inversely associated with BW z-score and the delivery of 
LGA newborns. In a case-control study, Kramer et al.33 also found that HDL-c concentrations were inversely asso-
ciated with BW, i.e., women who delivered SGA infants had higher concentrations of HDL-c compared to women 
who delivered AGA infants. Misra et al.14 evaluated the association between HDL-c concentrations at 10–14, 
16–20, 22–26 and 32–36 gestational weeks and BW in 143 American women stratified for pre-pregnancy BMI. 
The authors found an inverse and statistically significant association at all time points, but only in overweight/
obese women. Misra et al.14 also tested the influence of time-dependent changes in maternal serum HDL-c on 
BW and concluded that the trajectory of HDL-c change over time was not significantly associated with BW in 
any BMI category.
In our theoretical model, maternal BMI was considered a possible confounder of the relation between mater-
nal biomarkers (lipids, leptin and adiponectin) and BW since BMI is associated with both exposures and out-
come. Previous publications also tested BMI as an effect modifier of the relation between maternal lipids and 
BW14. To test if BMI had the same effect in our sample, we carried out regression models including interaction 
terms between lipids, leptin and adiponectin (intercept and slope) with early pregnancy BMI. In contrast to Misra 
et al.14, we did not find significant interactions in crude or adjusted models between BMI with any of the maternal 
biomarkers on BW. The difference observed between the two studies can be attributed to BW classifications and 
the statistical procedure adopted.
We observed that the rate of maternal LDL-c change during pregnancy was positively associated with BW 
z-score. Although some previous studies did not report this association6, 14, 17, Pecks et al.34 found that the mean 
LDL-c concentrations were lower in mothers of term (n = 5) and preterm (n = 10) intrauterine growth restricted 
newborns compared with term (n = 5) and preterm (n = 10) controls, respectively. The association reached sta-
tistical significance only between preterm groups. Merzouk et al.35 found that obese women who gave birth to 
macrosomic newborns had significantly higher concentrations of LDL-c than those who delivered newborns with 
a healthy weight.
We performed additional analyses to understand if the results of the present study remained the same when 
only the AGA subsample was considered. When LGA and SGA cases were simultaneously removed from the 
analysis, LDL-c and HDL-c lost the significant association with BW z-score. However, when only SGA cases were 
removed, HDL-c remained significantly associated. When only LGA cases were excluded, only LDL-c remained 
significantly associated with BW z-score. These analyses revealed that the associations between lipids and BW 
z-score were partially driven by the extremes of the BW distribution.
Variables
Total sample SGA1 AGA1 LGA1
p2 p3N % n % n % n %
Age (years)
 ≤30 141 70.8 9 6.4 105 74.5 27 19.1
0.545 0.508
 >30 58 29.2 2 3.4 47 81.0 9 15.5
Education (years of schooling)
 ≤8 87 43.7 5 5.8 68 78.2 14 16.1
0.519 1.000
 >8 112 56.3 6 5.4 84 75.0 22 19.6
Smoking habit
 No 187 94.0 10 5.4 141 75.4 36 19.2
0.093 0.581
 Yes 12 6.0 1 8.3 11 91.2 0 0.0
Alcohol consumption
 No 163 81.9 9 5.5 124 76.1 30 18.4
0.806 1.000
 Yes 36 18.1 2 5.6 28 77.8 6 16.7
Pre-pregnancy LTPA
 No 147 74.6 9 6.1 115 78.2 23 15.7
0.102 1.000
 Yes 50 25.4 2 4.0 35 70.0 13 26.0
Parity (parturitions)
 0 77 38.7 7 9.1 60 77.9 10 13.0
0.137 0.202
 ≥1 122 61.3 4 3.3 92 75.4 26 21.3
Pre-pregnancy BMI (kg/m²)
 18.5 - 24.9 112 59.6 8 7.1 89 79.5 15 13.4
0.042 0.325
 ≥25.0 76 40.4 2 2.6 55 72.4 19 25.0
Table 2. Distribution of maternal characteristics according to birth weight categories in a sample of pregnant 
women and their newborns followed at a public health centre in Rio de Janeiro city, Brazil, 2009–2012. 1Birth 
weight was classified according to the international foetal and newborn growth consortium for the 21st 
Century (Intergrowth-21st) curves. 2p-value refers to chi-square or Fisher’s exact test for proportions between 
AGA and LGA; 3p-value refers to chi-square or Fisher’s exact test for proportions between AGA and SGA. 
AGA = adequate for gestational age; BMI = body mass index; LGA = large for gestational age; LTPA = leisure 
time physical activity; SD = standard deviation; SGA = small for gestational age.
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Cholesterol is essential for foetal development; it is part of cell membranes, necessary for activation of var-
ious signalling pathways and a precursor of steroid hormones. Although most of foetal cholesterol is endoge-
nously obtained by de novo synthesis in the liver, there is evidence that maternal cholesterol (exogenous source) 
crosses the placenta and is important for foetal growth and impacts metabolic function of extraembryonic foetal 
tissues10, 36. Little is known about the biological mechanism by which maternal cholesterol affects BW, but it 
seems to include altered sterol hormone metabolism and impaired cell cycle and signalling of growth factors 
(including insulin) and is indirectly by affecting placental transport of nutrients12, 13, 36. This mechanism may 
be involved in the positive association between LDL-c and BW; however, it does not fully explain the inverse 
association between HDL-c and BW and LGA. We suppose that it may also be related to its antioxidant and 
anti-inflammatory properties37.
We did not find significant associations between maternal serum concentrations of TG and BW or LGA births, 
in line with results from Retnakaran et al.17 and Crume et al.38. TG concentrations are known to affect foetal 
growth in women who have gestational diabetes16, 39; however, in studies with non-diabetic women, it seems not 
to have the same impact on BW40.
We found a positive association between log leptin pregnancy baseline concentrations (intercept) and 
LGA births and no association between log leptin rate of change during pregnancy and BW z-score or LGA. 
Experimental studies have indicated a role of leptin in the regulation of the transfer of amino acids and lipids 
through the placenta41, 42; however, the literature remains contradictory, and there is no consensus regarding the 
Figure 1. HDL-cholesterol changes during pregnancy in a sample of 199 women and their newborns followed 
at a public health centre in Rio de Janeiro city, Brazil, 2009–2012. (A) Change per gestational week. (B) Change 
per gestational week according to birth weight categories. Note: The models were adjusted for age, education, 
smoking habit, pre-pregnancy leisure time physical activity, pre-pregnancy energy intake, glycaemia, parity, 
early pregnancy BMI, gestational weight gain and quadratic gestational age. Data are presented as linear mixed 
effect coefficient (β) and 95% CI. p-value refers to the maximum likelihood estimator. (A) Linear gestational 
age: β = 1.80 (1.52; 2.08), p < 0.001; Quadratic gestational age: β = −0.04 (−0.04; −0.03), p < 0.001. (B) SGA 
or AGA - Linear gestational age: β = 1.76 (1.44; 2.08), p < 0.001; quadratic gestational age; β = −0.04 (−0.04; 
−0.03), p < 0.001. LGA - Linear gestational age: β = 2.04 (1.42; 2.65), p < 0.001; gestational age; β = −0.04 
(−0.06; −0.03), p < 0.001.
www.nature.com/scientificreports/
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association between leptin concentrations and infant BW in humans. Our findings are in line with a study by 
Shrof et al.23, which evaluated 1,304 American women and found that those who delivered LGA neonates had 
higher leptin concentrations than women who delivered term AGA neonates. Franco-Sena et al.43 evaluated 195 
women between 8 and 13 weeks of gestation and found an association between lower concentrations of leptin and 
a higher risk of SGA. However, other authors have identified an inverse association between leptin concentrations 
and BW or LGA17 or did not find a significant association44. One possible explanation for these contradictory 
results is the difference in sample size or in the times of leptin assessment between these studies.
We did not find significant associations between total adiponectin and BW z-score or LGA births. Ong et 
al.28 also did not find significant associations between total adiponectin and BW in a sample of 58 women of 
Caucasian descent with singleton pregnancies. However, they found a borderline significant association between 
HMW adiponectin and BW and a significant inverse association between the ratio of HMW to total adiponectin 
and BW (β = −19.2; p = 0.018). In contrast, Retnakaran et al.17 found a significant inverse association between 
total adiponectin in the third trimester and BW in a sample of 422 women without GDM. Although we did not 
find statistically significant associations between total adiponectin and BW, we observed the same trend reported 
by Retnakaran et al.17. We hypothesize that the lack of association observed in our study and in the one conducted 
by Ong et al.28 could be attributed to the sample sizes.
This prospective study of low-income women found that maternal HDL-c and LDL-c rates of change during 
pregnancy were associated with BW z-score, even after adjusting for important confounders such as maternal 
Figure 2. LDL-cholesterol changes during pregnancy in a sample of 199 women and their newborns followed 
at a public health centre in Rio de Janeiro city, Brazil, 2009–2012. (A) Change per gestational week. (B) Change 
per gestational week according to birth weight categories. Note: The models were adjusted for age, education, 
smoking habit, pre-pregnancy leisure time physical activity, pre-pregnancy energy intake, glycaemia, parity, 
early pregnancy BMI, gestational weight gain and quadratic gestational age. Data are presented as linear mixed 
effect coefficient (β) and 95% CI. p-value refers to the maximum likelihood estimator. (A) Linear gestational 
age: β = 3.46 (2.77; 4.14), p < 0.001; Quadratic gestational age: β = −0.042 (−0.06; −0.02), p < 0.001. (B) SGA 
or AGA - Linear gestational age: β = 3.11 (2.38; 3.83), p < 0.001; quadratic gestational age; β = −0.03 (−0.05; 
−0.02), p < 0.001. LGA - Linear gestational age: β = 4.956 (3.30; 6.62), p < 0.001; gestational age; β = −0.08 
(−0.12; −0.04), p < 0.001.
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early pregnancy BMI, GWG and fasting glucose. We also observed that leptin concentrations were positively asso-
ciated with LGA births. The association between HDL-c and log leptin with LGA births persists even when we 
enter both variables in the fully adjusted model. There are no established gestational cut-off points for the assess-
ment of lipid concentrations, so any alteration is considered a physiological adaptation of pregnancy. However, 
our results indicate that lipids and leptin are important to foetal growth and that in the future, the evaluation of 
lipid changes and leptin concentrations during pregnancy may be used as an additional strategy to screen women 
at risk of delivering LGA newborns. Although we found relevant associations, additional studies exploring these 
relationships in different populations and with lager sample sizes are needed to propose specific cut-off points.
Methods
Setting and participants. We conducted a prospective cohort study in pregnant women at a municipal 
health centre in Rio de Janeiro, Brazil from November 2009 to June 2012. Eligibility criteria were: age between 20 
to 40 years and pregnancy between 5 and 13 completed weeks of gestation, with no known chronic non-commu-
nicable diseases (except obesity).
Women were studied at three time points during pregnancy: weeks 5–13 [median (IQR) = 9.4 (7.8; 11.3)], 
20–26 [median (IQR) = 23.4 (22.1; 24.4)], and 30–36 [median (IQR) = 31.8 (30.4; 33.8)] and at a fourth visit 
between 30 and 45 days post-partum. A total of 322 women were invited to participate and 299 were enrolled 
in the study. After baseline clinical evaluation 50 women were excluded for the following reasons: a confirmed 
Figure 3. Total cholesterol changes during pregnancy in a sample of 199 women and their newborns followed 
at a public health centre in Rio de Janeiro city, Brazil, 2009–2012. (A) Change per gestational week. (B) Change 
per gestational week according to birth weight categories. Note: The models were adjusted for age, education, 
smoking habit, pre-pregnancy leisure time physical activity, pre-pregnancy energy intake, glycaemia, parity, 
early pregnancy BMI, gestational weight gain and quadratic gestational age. Data are presented as linear mixed 
effect coefficient (β) and 95% CI. p-value refers to the maximum likelihood estimator.(A) Linear gestational 
age: β = 6.21 (5.36; 7.05), p < 0.001; Quadratic gestational age: β = −0.085 (−0.10; −0.07), p < 0.001. (B) SGA 
or AGA - Linear gestational age: β = 5.88 (4.98; 6.78), p < 0.001; quadratic gestational age; β = −0.08 (−0.10; 
−0.06), p < 0.001. LGA - Linear gestational age: β = 7.67 (5.50; 9.83), p < 0.001; gestational age; β = −0.12 
(−0.17; −0.07), p < 0.001.
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pre-pregnancy diagnosis of chronic non-communicable diseases, including women with fasting glucose values 
≥126 mg/dL at the 1st trimester (n = 12); the presence of infectious or parasitic diseases (n = 9); twin pregnancy 
(n = 4); and miscarriage (n = 25). We further excluded women with missing values for BW or gestational age at 
birth (n = 24), with baseline underweight (BMI < 18.5 kg/m²; n = 4) and women with no lipid measurements at 
the first trimester (n = 22). The baseline sample comprised 199 pregnant women. Thirteen women reported a 
diagnosis of GDM during pregnancy (6.5%), and two developed hypertension (>140 and/or >90 mmHg systolic 
and diastolic respectively) during pregnancy.
Measurements. BW (g) was obtained from the child vaccination booklet at the post-partum interview. 
We also evaluated BW z-score for gestational age and sex according to the international foetal and newborn 
growth consortium for the 21st Century (Intergrowth-21st) curves31. We classified newborns as LGA when the 
BW, according to the gestational age and sex-specific Intergrowth-21st curves, was above the 90th percentile and 
as SGA when it was below the 10th percentile.
The gestational age was calculated based on data from the first ultrasonography examination if it was per-
formed prior to 24 weeks of gestation (n = 189; 95.0%). In cases where this measure was unavailable, the date of 
the last menstrual period was used (n = 10; 5.0%). The gestational age at delivery was calculated based on the date 
of birth reported at the post-partum visit.
During each trimester of pregnancy, a nurse technician collected two fasting blood samples (2.5 mL) from 
each woman in vacutainer tubes containing EDTA or separator gel. The samples were centrifuged (5 minutes, 
5031 g), and the serum and plasma were immediately stored at −80 °C.
Figure 4. Triglycerides changes during pregnancy in a sample of 199 women and their newborns followed at 
a public health centre in Rio de Janeiro city, Brazil, 2009–2012. (A) Change per gestational week. (B) Change 
per gestational week according to birth weight categories. Note: The models were adjusted for age, education, 
smoking habit, pre-pregnancy leisure time physical activity, pre-pregnancy energy intake, glycaemia, parity, 
early pregnancy BMI, gestational weight gain and quadratic gestational age. Data are presented as linear mixed 
effect coefficient (β) and 95% CI. p-value refers to the maximum likelihood estimator. (A) Linear gestational 
age: β = 3.52 (3.26; 3.78), p < 0.001. (B) SGA or AGA - Linear gestational age: β = 3.45 (3.16; 3.74), p < 0.001. 
LGA - Linear gestational age: β = 3.79 (3.23; 4.35), p < 0.001.
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Serum samples were analysed at the Faculty of Pharmacy Clinical Analysis Laboratory (Rio de Janeiro Federal 
University) for total cholesterol (TC; mg/dL), HDL-c (mg/dL) and TG (mg/dL) by using the enzymatic colorimet-
ric method and an automated analyser (Labmaxplenno®, LabtestDiagnóstica, Minas Gerais, Brazil) and commer-
cial kits (LabtestDiagnóstica). LDL-c (mg/dL) was calculated as follows: TC - HDL-c - (TG/5)45.
Plasma leptin (ng/mL) and total adiponectin (µg/mL) concentrations were measured during the three preg-
nancy trimesters using commercial ELISA kits (Millipore, St. Charles, Missouri, USA), with sensitivities of 
0.50 ng/dL and 0.78 µg/mL, respectively.
Maternal characteristics recorded at baseline included age (years), monthly per capita family income (US$), 
education (years of schooling), current smoking habits (no or yes), alcohol consumption (no or yes), parity (0 or 
≥1 parturitions), and pre-pregnancy LTPA (no or yes). The sex of the newborn (male or female) was reported in 
the post-partum questionnaire.
Maternal body weight (kg) was obtained using a digital scale (Filizzola PL 150, FilizzolaLtda, Brazil). Height 
was measured twice, using a portable stadiometer at baseline (Seca Ltd., Hamburgo, Germany). Early pregnancy 
BMI [weight (kg)/height (m)2] was calculated based on first trimester weight and height. The cutoff point pro-
posed by the Institute of Medicine46 was used to classify the women during early pregnancy as normal weight 
(18.5 to 24.9 kg/m2) or as overweight/obese (≥25.0 kg/m2). Anthropometric measures were collected according 
to standardized procedures and performed by trained interviewers47.
Figure 5. Leptin changes during pregnancy in a sample of 199 women and their newborns followed at a 
public health centre in Rio de Janeiro city, Brazil, 2009–2012. (A) Change per gestational week. (B) Change 
per gestational week according to birth weight categories. Note: The models were adjusted for age, education, 
smoking habit, pre-pregnancy leisure time physical activity, pre-pregnancy energy intake, glycaemia, parity, 
early pregnancy BMI, gestational weight gain and quadratic gestational age. Data are presented as linear mixed 
effect coefficient (β) and 95% CI. p-value refers to the maximum likelihood estimator. (A) Linear gestational 
age: β = 1.60 (0.98; 2.22), p < 0.001; Quadratic gestational age: β = −0.027 (−0.04; −0.01), p = 0.001. (B) SGA 
or AGA - Linear gestational age: β = 1.74 (1.07; 2.42), p < 0.001; quadratic gestational age; β = −0.029 (−0.04; 
−0.01), p < 0.001. LGA - Linear gestational age: β = 1.33 (−0.14; 2.81), p = 0.077; gestational age; β = −0.02 
(−0.06; −0.01), p = 0.233.
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GWG (kg) was calculated as the difference between the last weight measured before delivery (mean gesta-
tional age = 37.9 weeks; SD = 2.3) and the first trimester weight (mean gestational age = 9.6 weeks; SD = 2.2).
Fasting glucose (mg/dL) was measured in all pregnancy trimesters using the glucose oxidase-peroxidase enzy-
matic colorimetric method and a Wiener Lab kit (Rosario, Argentina).
Total energy intake was assessed using a semi-quantitative food frequency questionnaire (FFQ) validated for 
the adult population of Rio de Janeiro48. The FFQ was composed of 81 food items, eight frequency options and 
household measure portion options. The FFQ was administered at the first gestational trimester (5–13 weeks of 
gestation) and referred to food intake 6 months prior to pregnancy. For statistical analysis, frequency options 
were transformed into daily frequencies and household measures into grams (g) or milliliters (ml)49. The daily 
amount consumed (g or ml/day) of each food item was obtained by multiplying the daily frequency (3x/day; 2 
to 3x/day; 1x/day; 5 to 6x/week; 2 to 4x/week; 1x/week; 1 a 3x/month and never or almost never) per portion 
size. The Brazilian Food Composition Table (TACO)50 was used as the main database to determine food nutri-
tional composition and The National Nutrient Database for Standard Reference provided by the United States 
Department of Agriculture51 was considered as a secondary option when a food item was not available in the 
TACO database.
Ethics. The research ethics committee of the Municipal Secretary of Health of Rio de Janeiro Municipality 
(Protocol number: 0139.0.314.000-09, approved on 13 August 2009) approved the study protocol. All participants 
Figure 6. Adiponectin changes during pregnancy in a sample of 199 women and their newborns followed at 
a public health centre in Rio de Janeiro city, Brazil, 2009–2012. (A) Change per gestational week. (B) Change 
per gestational week according to birth weight categories. Note: The models were adjusted for age, education, 
smoking habit, pre-pregnancy leisure time physical activity, pre-pregnancy energy intake, glycaemia, parity, 
early pregnancy BMI, gestational weight gain and quadratic gestational age. Data are presented as linear mixed 
effect coefficient (β) and 95% CI. p-value refers to the maximum likelihood estimator. (A) Linear gestational 
age: β = 0.19 (0.03; 0.34), p = 0.018; Quadratic gestational age: β = −0.004 (−0.01; −0.0003), p = 0.033. (B) SGA 
or AGA - Linear gestational age: β = 0.21 (0.03; 0.39), p = 0.021; quadratic gestational age; β = −0.004 (−0.01; 
−0.0002), p = 0.042. LGA - Linear gestational age: β = 0.13 (−0.02; 0.29), p = 0.096; gestational age; β = −0.004 
(−0.01; 0.0003), p = 0.031.
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signed a consent agreement, which was obtained freely and spontaneously, after all necessary clarifications had 
been provided. All ethical procedures of this study involving human beings followed the Brazilian Resolution 
196/96.
Statistical analysis. General characteristics of the sample were described as the means and standard devi-
ations (SD) for continuous variables and proportions (%) for categorical variables. Student’s unpaired t test was 
used to compare means, and the chi-square test was used for proportions. The mean variation (SD) between the 
first and the third trimester biomarkers values was calculated.
To evaluate the association between biomarker changes during pregnancy and BW z-scores and LGA, we 
used a two-stage method. (1) We constructed a linear mixed-effect model (LME) for each exposure (maternal 
lipids, leptin and adiponectin) including gestational age at sampling as fixed and random effects and estimated 
the best linear unbiased prediction (BLUP) of random coefficients. The predicted intercept refers to the mean 
lipid, leptin or adiponectin exposure level, i.e., the biomarker concentrations when the gestational age was zero, 
and was labelled as the pregnancy baseline concentration. The predicted slope refers to the rate in concentration 
changes per gestational age during pregnancy. (2) The BLUP predicted intercept and slope were simultaneously 
included as continuous predictors in linear and logistic regression models having BW z-score and LGA as out-
comes, respectively. This approach considers that repeated measures are correlated and estimates time trends of 
exposure even for women with missing values across pregnancy, increasing the power of the analysis32. Since the 
LME model assumes that the dependent variable is normally distributed, we have log transformed variables with 
skewed distribution (TG, leptin and adiponectin).
The modelling process was performed in three steps. We constructed three linear (outcome: BW z-score) and 
three logistic (outcome: LGA) regression models to test the association between maternal biomarkers (lipids, 
leptin and adiponectin) and BW z-score or LGA births, reporting the regression coefficient (β) and odds ratio 
(OR), respectively, and their 95% confidence intervals (95% CI). In the first models, lipids, leptin and adiponectin 
intercept and slope variables were included together in the same model. The second models were additionally 
adjusted for age (years), education (years of schooling), pre-pregnancy LTPA (no/yes), smoking habit (no/yes), 
parity (number of parturitions), total pre-pregnancy energy intake (kcal/day), fasting glucose (mg/dL) and GWG 
(kg). In the third models, the early pregnancy BMI variable was added. We also tested if there was an interaction 
between maternal BMI and lipids, leptin or adiponectin on BW z-score and LGA births. The adjustment variables 
were chosen based on the biological plausibility of the association.
Since the models were adjusted for variables that could be correlated with each other, we tested the correlation 
between them. Variables with strong correlations (Pearson or Spearman coefficient ≥0.7) were candidates to be 
excluded. The TC was not included in the fully adjusted models due to its strong correlation with HDL-c and 
LDL-c.
Variables N
Birth weight z-score1
Mean (SD) p2
Age (years)
 ≤30 141 0.28 (1.09)
0.470
 >30 58 0.40 (1.01)
Education (years of schooling)
 ≤8 87 0.30 (1.03)
0.893
 >8 112 0.32 (1.09)
Smoking habit
 No 187 0.33 (1.07)
0.210
 Yes 12 −0.06 (0.98)
Alcohol consumption
 No 163 0.32 (1.05)
0.835
 Yes 36 0.28 (1.13)
Pre-pregnancy LTPA
 No 147 0.25 (1.00)
0.119
 Yes 50 0.52 (1.22)
Parity (parturitions)
 0 77 0.14 (1.08)
0.072
 ≥1 122 0.42 (1.04)
Pre-pregnancy BMI (kg/m²)
 18.5–24.9 112 0.22 (1.07)
0.103
 ≥25.0 76 0.48 (1.05)
Table 3. Mean birth weight z-score according to maternal characteristics in a sample of pregnant women 
and their newborns followed at a public health centre in Rio de Janeiro city, Brazil, 2009–2012. 1Birth weight 
z-score was classified according to the international foetal and newborn growth consortium for the 21st Century 
(Intergrowth-21st) curves. 2p-value refers to unpaired Student’s t test. Abbreviations: BMI = body mass index; 
LGA = large for gestational age; LTPA = leisure time physical activity; SD = standard deviation.
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We further investigated the occurrence of multicollinearity in the full models using the variance inflation 
factor. We predicted residuals and fitted values of the outcomes for our final models. We checked normality of 
the residuals and constructed two-way scatter plots between the residuals and predicted values of BW to detect 
outlying observations and to check the assumption of constant variability of outcomes across values of exposure 
(homoscedasticity) and scatter patterns of the residuals52.
LGA1
Model 1 (n = 199) Model 2 (n = 186) Model 3 (n = 186)
OR2 (95% 
CI) p3 OR2 (95% CI) p3
OR2 (95% 
CI) p3
HDL-cholesterol
 Intercept 1.11 (1.00 to 1.24) 0.050
1.09 (0.96 to 
1.23) 0.170
1.10 (0.97 to 
1.24) 0.135
 Slope 0.01 (0.0002 to 0.29) 0.009
0.02 (0.0004 to 
1.09) 0.055
0.02 (0.0003 
to 0.88) 0.043
LDL-cholesterol
 Intercept 0.99 (0.95 to 1.03) 0.553
1.00 (0.96 to 
1.04) 0.898
0.99 (0.95 to 
1.03) 0.751
 Slope 1.69 (0.95 to 2.99) 0.073
1.46 (0.77 to 
2.74) 0.245
1.52 (0.80 to 
2.88) 0.203
Log triglycerides
 Intercept 0.96 (0.19 to 4.83) 0.965
1.30 (0.23 to 
7.42) 0.772
1.09 (0.18 to 
6.51) 0.922
 Slope
4.5e + 34 
(2.8e–07 to 
7.2e + 75)
0.099
9.3e + 42 
(0.005 to 
1.8e + 88)
0.063
1.0e + 43 
(0.001 to 
9.5e + 88)
0.067
Log leptin
 Intercept 3.89 (1.49 to 10.09) 0.005
5.35 (1.84 to 
15.57) 0.002
3.92 (1.18 to 
12.95) 0.025
 Slope 0.04 (3.6e–46 to 3.4e + 42) 0.948
7.1e–15 
(3.0e–62to 
1.7e + 32)
0.558
1.1e–10 
(7.4e–59 to 
1.5e–38)
0.685
Log adiponectin
Intercept 0.34 (0.12 to 1.00) 0.049
0.53 (0.16 to 
1.81) 0.314
0.54 (0.16 to 
1.83) 0.321
Slope
45.47 
(1.5e–18 to 
1.4e + 21)
0.868 76.4 (1.0e–19 to 5.6e + 22) 0.860
0.26 (1.4e–22 
to 4.6e + 20) 0.957
Age (years) — — 0.94 (0.86 to 1.04) 0.236
0.95 (0.86 to 
1.04) 0.266
Education — — 1.03 (0.86 to 1.22) 0.765
1.03 (0.87 to 
1.22) 0.732
Pre-pregnancy LTPA 
(no/yes) — —
1.76 (0.65 to 
4.80) 0.268
1.82 (0.66 to 
4.98) 0.246
Parity (n of parturitions) — — 1.55 (1.01 to 2.40) 0.045
1.52 (0.98 to 
2.35) 0.061
Pre-pregnancy energy 
intake (kcal/day) — —
1.00 (1.00 to 
1.001) 0.597
1.00 (1.00 to 
1.00) 0.662
Glycaemia (mg/dL) — — 0.97 (0.92 to 1.02) 0.287
0.97 (0.92 to 
1.02) 0.232
Gestational weight gain 
(kg) — —
1.08 (0.97 to 
1.21) 0.146
1.09 (0.97 to 
1.21) 0.142
Early pregnancy BMI 
(kg/m2) — — — —
1.07 (0.94 to 
1.21) 0.292
Table 4. Logistic regression between maternal lipids, log leptin and log adiponectin time trends during 
pregnancy and large-for-gestational-age (LGA)1 in a sample of women and their newborns followed at a public 
health centre in Rio de Janeiro city, Brazil, 2009–2012. 1LGA was classified according to the international 
foetal and newborn growth consortium for the 21st Century (Intergrowth-21st) curves. 2Odds ratio. 3p-value 
refers to the logistic regression. Notes: Intercept variables represent the prediction of the mean exposure 
level, i.e. biomarkers concentrations when the gestational age was zero and the slope the trend of change 
in concentrations during pregnancy. Model 1 included lipids, leptin and adiponectin intercepts and slopes 
variables; Model 2 was additionally adjusted for women’s age, education, parity, pre-pregnancy practice of 
leisure time physical activity, pre-pregnancy energy intake, glycaemia and gestational weight gain. Model 3 was 
additionally adjusted for early pregnancy BMI. The models were not adjusted by smoking habit since none of 
the mothers of LGA smoked during pregnancy. Abbreviations: CI = confidence interval; HDL-c = high-density 
lipoprotein; LDL-c = low-density lipoprotein; LGA = large-for-gestational-age; LTPA = leisure time physical 
activity.
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Birth weight z-score1
Model 1 (n = 199) Model 2 (n = 186) Model 3 (n = 186)
β2 (95% CI) p3 β2 (95% CI) p3 β2 (95% CI) p3
HDL-cholesterol
 Intercept 0.06 (0.01 to 0.10) 0.008
0.04 (−0.01 
to 0.08) 0.095
0.04 (−0.001 
to 0.82) 0.054
 Slope
−2.15 
(−3.47 to 
−0.83)
0.002
−1.85 
(−3.18 to 
−0.53)
0.006 −1.99 (−3.30 to −0.68) 0.003
LDL-cholesterol
 Intercept
−0.01 
(−0.02 to 
0.01)
0.376
−0.01 
(−0.02 to 
0.01)
0.354 −0.01 (−0.02 to 0.01) 0.204
 Slope 0.36 (0.15 to 0.58) 0.001
0.27 (0.06 to 
0.48) 0.012
0.31 (0.10 to 
0.52) 0.004
Log triglycerides
 Intercept 0.11 (−0.46 to 0.68) 0.702
0.21 (−0.38 
to 0.80) 0.444
0.11 (−0.48 to 
0.68) 0.714
 Slope
13.50 
(−18.60 to 
45.60)
0.408
14.04 
(−18.35 to 
47.08)
0.387 12.37 (−19.89 to 44.64) 0.450
Log leptin
 Intercept 0.42 (0.10 to 0.74) 0.010
0.43 (0.10 to 
0.75) 0.010
0.19 (−0.18 to 
0.56) 0.306
 Slope
−15.96 
(−53.67 to 
21.76)
0.405
−21.97 
(−60.43 to 
16.49)
0.261
−14.34 
(−52.71 to 
24.02)
0.461
Log adiponectin
 Intercept
−0.13 
(−0.48 to 
0.22)
0.469 0.06 (−0.29 to 0.42) 0.736
0.10 (−0.25 to 
0.45) 0.555
 Slope
11.43 
(−5.22 to 
28.08)
0.177 10.77 (−5.67 to 27.20) 0.171
8.31 (−8.09 to 
24.72) 0.359
Age (years) — —
−0.001 
(−0.03 to 
0.03)
0.963 −0.001 (−0.03 to 0.03) 0.959
Education (years of 
schooling) — —
0.01 (−0.04 
to 0.07) 0.707
0.01 (−0.04 to 
0.07) 0.699
Smoking habit (no/yes) — —
−0.03 
(−0.70 to 
0.64)
0.924 −0.08 (−0.74 to 0.58) 0.816
Pre-pregnancy LTPA (no/
yes) — —
0.18 (−0.17 
to 0.54) 0.308
0.21 (−0.14 to 
0.55) 0.243
Parity (n of parturitions) — — 0.14 (−0.004 to 0.30) 0.055
0.13 (−0.02 to 
0.29) 0.083
Pre-pregnancy energy 
intake (kcal/day) — —
−0.0001 
(−0.003 to 
0.0001)
0.246
−0.0001 
(−0.0003 to 
0.0001)
0.246
Glycaemia (mg/dL) — —
−0.01 
(−0.02 to 
0.01)
0.294 −0.01 (−0.03 to 0.01) 0.185
Gestational weight gain 
(kg) — —
0.04 (0.01 to 
0.08) 0.016
0.05 (0.01 o 
0.09) 0.009
Early pregnancy BMI 
(kg/m2) — — — —
0.06 (0.01 to 
0.10) 0.014
Table 5. Linear regression between maternal lipids, log leptin and log adiponectin time trends during 
pregnancy and birth weight z-score1 in a sample of women and their newborns followed at a public health 
centre in Rio de Janeiro city, Brazil, 2009–2012. 1Birth weight was classified according to the international 
foetal and newborn growth consortium for the 21st Century (Intergrowth-21st) curves. 2Linear regression 
coefficient.3p-value refers to the linear regression. Notes: Intercept variables represent the prediction of 
the mean exposure level, i.e. biomarkers concentrations when the gestational age was zero and the slope 
variables represent the trend of change in concentrations during pregnancy. Model 1 included lipid, leptin and 
adiponectin intercepts and slopes variables; Model 2 was additionally adjusted for women’s age, education, 
parity, smoking habit, pre-pregnancy practice of leisure time physical activity, pre-pregnancy energy intake, 
glycaemia and gestational weight gain. Model 3 was additionally adjusted for early pregnancy body mass index. 
Abbreviations: CI = confidence interval; HDL-c = high-density lipoprotein; LDL-c = low-density lipoprotein; 
LTPA = leisure time physical activity.
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Effect plots were created to present the longitudinal prediction of maternal biomarker changes during preg-
nancy for the total sample and according to BW categories (SGA or AGA vs. LGA). In these plots, the longitudinal 
prediction and 95% CI (black line and shaded area, respectively) represent the effect of gestational age and quad-
ratic gestational age, when applicable, on maternal lipids, leptin and adiponectin. The effect plots were adjusted 
for age, education, smoking habit, pre-pregnancy LTPA, pre-pregnancy energy intake, glycaemia, parity, early 
pregnancy BMI, and gestational weight gain, but no adjustments were made for multiple comparisons.
Statistical analyses were performed using Stata Data Analysis and Statistical Software (STATA) version 12.0 
(Stata Corp., College Station, Texas, USA). Values were considered statistically significant when the p-value was 
lower than 0.05.
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